Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.
Sood A, McClain D, Maitra R, Basu-Mallick A, Seetharam R, Kaubisch A, Rajdev L, Mariadason JM, Tanaka K, Goel S. Sood A, et al. Among authors: maitra r. Clin Colorectal Cancer. 2012 Jun;11(2):143-50. doi: 10.1016/j.clcc.2011.12.001. Epub 2012 Jan 28. Clin Colorectal Cancer. 2012. PMID: 22285706 Free PMC article.
Reovirus: a targeted therapeutic--progress and potential.
Maitra R, Ghalib MH, Goel S. Maitra R, et al. Mol Cancer Res. 2012 Dec;10(12):1514-25. doi: 10.1158/1541-7786.MCR-12-0157. Epub 2012 Oct 4. Mol Cancer Res. 2012. PMID: 23038811 Free PMC article. Review.
Immunotherapeutic advances in gastrointestinal malignancies.
Rao D, Parakrama R, Augustine T, Liu Q, Goel S, Maitra R. Rao D, et al. Among authors: maitra r. NPJ Precis Oncol. 2019 Feb 5;3:4. doi: 10.1038/s41698-018-0076-8. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 30729176 Free PMC article. Review.
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin.
Rao D, Mallick AB, Augustine T, Daroqui C, Jiffry J, Merla A, Chaudhary I, Seetharam R, Sood A, Gajavelli S, Aparo S, Rajdev L, Kaubisch A, Chuy J, Negassa A, Mariadason JM, Maitra R, Goel S. Rao D, et al. Among authors: maitra r. Oncotarget. 2019 Sep 17;10(53):5510-5522. doi: 10.18632/oncotarget.27140. eCollection 2019 Sep 17. Oncotarget. 2019. PMID: 31565185 Free PMC article.
224 results